Veran Medical Technologies Inc. is a medical device company and leader in image-guided endobronchial and percutaneous technology for diagnosis of lung cancer and therapy delivery.
Veran Medical secures $31 million to accelerate commercialization and innovation of SPiN Thoracic Navigation System™ Technology Platform
Veran Medical Technologies today announced the closing of a $31 million debt and equity financing. The debt financing is provided by Oxford Finance LLC (“Oxford”), a specialty finance firm that provides senior debt to life sciences and healthcare services companies, and the equity financing was completed by existing investors Versant Ventures and River Cities Capital Funds.
Published study from Johns Hopkins finds that same day procedural CT scans for Lung Cancer may reduce unnecessary procedures and patient risk
Retrospective analysis of 116 patients scheduled for navigated bronchoscopy utilizing Veran Medical’s SPiN System™ finds 15 screens needed to prevent one unnecessary procedure.
The Hurley Lung Center is now open. Located inside the hospital, the center offers a unique perk for patients: a lung navigator.
Veran Medical Launches New Lung Navigation Software, Hardware and Lung Access Tools Designed to Enable Faster Diagnosis and Earlier Treatment of Lung Cancer
Products debut at CHEST 2016 in Los Angeles, October 24th, 2016.
To provide medical device and technology companies with a greater perspective on successfully navigating VACs, we spoke with four River Cities’ med tech portfolio companies that have dedicated countless hours to mastering the pathway to get innovative products in front of and approved by these ever-vigilant committees.